Modulation of CD4+ and CD8+ T Cell Function and Cytokine Responses in Strongyloides stercoralis Infection by Interleukin-27 (IL-27) and IL-37

Infect Immun. 2017 Oct 18;85(11):e00500-17. doi: 10.1128/IAI.00500-17. Print 2017 Nov.

Abstract

Strongyloides stercoralis infection is associated with diminished antigen-specific Th1- and Th17-associated responses and enhanced Th2-associated responses. Interleukin-27 (IL-27) and IL-37 are two known anti-inflammatory cytokines that are highly expressed in S. stercoralis infection. We therefore wanted to examine the role of IL-27 and IL-37 in regulating CD4+ and CD8+ T cell responses in S. stercoralis infection. To this end, we examined the frequency of Th1/Tc1, Th2/Tc2, Th9/Tc9, Th17/Tc17, and Th22/Tc22 cells in 15 S. stercoralis-infected individuals and 10 uninfected individuals stimulated with parasite antigen following IL-27 or IL-37 neutralization. We also examined the production of prototypical type 1, type 2, type 9, type 17, and type 22 cytokines in the whole-blood supernatants. Our data reveal that IL-27 or IL-37 neutralization resulted in significantly enhanced frequencies of Th1/Tc1, Th2/Tc2, Th17/Tc17, Th9, and Th22 cells with parasite antigen stimulation. There was no induction of any T cell response in uninfected individuals following parasite antigen stimulation and IL-27 or IL-37 neutralization. Moreover, we also observed increased production of gamma interferon (IFN-γ), IL-5, IL-9, IL-17, and IL-22 and decreased production of IL-10 following IL-27 and IL-37 neutralization and parasite antigen stimulation in whole-blood cultures. Thus, we demonstrate that IL-27 and IL-37 limit the induction of particular T cell subsets along with cytokine responses in S. stercoralis infections, which suggest the importance of IL-27 and IL-37 in immune modulation in a chronic helminth infection.

Keywords: T cells; cytokines; helminths; immune mechanisms.

MeSH terms

  • Animals
  • Antibodies, Neutralizing / pharmacology
  • Antigens, Helminth / pharmacology
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / parasitology
  • Case-Control Studies
  • Chronic Disease
  • Gene Expression Regulation
  • Host-Pathogen Interactions*
  • Interferon-gamma / genetics
  • Interferon-gamma / immunology
  • Interleukin-1 / antagonists & inhibitors
  • Interleukin-1 / genetics
  • Interleukin-1 / immunology*
  • Interleukin-13 / genetics
  • Interleukin-13 / immunology
  • Interleukin-17 / genetics
  • Interleukin-17 / immunology
  • Interleukin-22
  • Interleukin-4 / genetics
  • Interleukin-4 / immunology
  • Interleukin-5 / genetics
  • Interleukin-5 / immunology
  • Interleukin-9 / genetics
  • Interleukin-9 / immunology
  • Interleukins / antagonists & inhibitors
  • Interleukins / genetics
  • Interleukins / immunology*
  • Primary Cell Culture
  • Signal Transduction
  • Strongyloides stercoralis / growth & development
  • Strongyloides stercoralis / immunology*
  • Strongyloidiasis / genetics
  • Strongyloidiasis / immunology*
  • Strongyloidiasis / parasitology
  • Th1 Cells / drug effects
  • Th1 Cells / immunology
  • Th1 Cells / parasitology
  • Th17 Cells / drug effects
  • Th17 Cells / immunology
  • Th17 Cells / parasitology
  • Th2 Cells / drug effects
  • Th2 Cells / immunology
  • Th2 Cells / parasitology

Substances

  • Antibodies, Neutralizing
  • Antigens, Helminth
  • IL37 protein, human
  • IL4 protein, human
  • IL5 protein, human
  • IL9 protein, human
  • Interleukin-1
  • Interleukin-13
  • Interleukin-17
  • Interleukin-5
  • Interleukin-9
  • Interleukins
  • MYDGF protein, human
  • Interleukin-4
  • Interferon-gamma